Owner Biosynexus Incorporated

Inventors Lees, Andrew; Mond, James J; Stinson, Jeffrey R; Grinberg, Lioubov; KokaiKun, John F

Agent Griffith Hack

Pub. Number AU-B-2002367820

PCT Number PCT/US02/40924

PCT Pub. Number WO2003/082184

Priority 60/341,804 21.12.01 US

Filing date 23 December 2002

Wipo publication date 13 October 2003

Acceptance publication date 1 November 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/48 (2006.01) Enzymes, e.g. ligases (6.) - acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)

C12N 9/52 (2006.01) Enzymes, e.g. ligases (6.) - derived from bacteria

C12N 9/80 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12R 1/19 (2006.01)